ASTRAZEN
PharmaceuticalsAstraZeneca Pharma India Ltd.
NSE: ASTRAZENBSE: 506820ISIN: INE203A01020
₹7,112.50
-40.50 · -0.57%
As of 27 Aug 2026
Open
₹7,170.00
High
₹7,170.00
Low
₹7,070.00
Prev Close
₹7,153.00
52W High
₹9,849.50
52W Low
₹7,070.00
Volume
3.2 K
Mkt Cap
₹17,791 Cr
Fundamentals
Valuation & profitability
Market Cap
₹17,791 Cr
P/E Ratio
119
EPS (TTM)
₹59.77
Book Value
₹285.00
Dividend Yield
0.34%
ROCE
31.1%
ROE
22.9%
Sales Growth
17%
Face Value
₹2.00
Company overview
AstraZeneca Pharma India Ltd.
Parent organization: Astra Pharmaceuticals AB
AstraZeneca Pharma India Limited is a global biopharmaceutical company.
The Company is engaged in the discovery, development, and commercialization of medicines for healthcare, including cardiovascular/metabolic disease, cancer, and respiratory, inflammatory, and autoimmune disease.
The Company operates through two segments:
The Healthcare segment engages in the manufacture and sale of pharmaceutical products.
The Clinical Trial segment renders clinical trial services on pharmaceutical products to its group companies.
Key highlights
Auto-generated from live data
- Trades at a P/E of 119, with a return on equity (ROE) of 22.9%.
- ASTRAZEN is trading below all of its key moving averages (10/20/50/100/200-DMA) — a bearish technical setup.
- Year-to-date it is down 17.78%, and down 20.96% over the past year.
- At ₹7,112.50 it sits about 2% of the way up its 52-week range (₹7,070.00–₹9,849.50).
- Offers a dividend yield of 0.34%.
- Market capitalisation stands at ₹17,791 Cr.
Price chart
Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC
Shareholding pattern
Shareholding data syncs daily.
Performance
Stock returns vs Nifty 50
10D
-5.91%
Nifty -0.08%
20D
-11.14%
Nifty -1.28%
50D
-11.85%
Nifty +1.69%
100D
-15.74%
Nifty +2.63%
200D
-16.83%
Nifty -6.10%
YTD
-17.78%
Nifty -7.30%
52W
-20.96%
Nifty -7.06%
Moving averages
Simple moving averages vs current price
SMA 10-Day
₹7,478.50Below
SMA 20-Day
₹7,790.40Below
SMA 50-Day
₹8,046.56Below
SMA 100-Day
₹8,236.97Below
SMA 200-Day
₹8,496.23Below
Price ranges
Where the price sits in each window
10-Day range₹7,112.50
₹7,110.00₹7,922.50
20-Day range₹7,112.50
₹7,110.00₹8,510.00
50-Day range₹7,112.50
₹7,110.00₹8,784.00
200-Day range₹7,112.50
₹7,110.00₹9,580.00
YTD range₹7,112.50
₹7,110.00₹9,220.00
52-Week range₹7,112.50
₹7,110.00₹9,849.50
Technical signals
Unfilled gaps acting as support / resistance
Unfilled Gap Up On 30 Aug, 2023 : 4203.00 ~ 4201.85SUPPORT
Unfilled Gap Up On 31 Mar, 2020 : 2300.00 ~ 2290.00SUPPORT
Annual financials
Revenue, profit & EPS by financial year
| Year | Revenue | Net Profit | EPS | NPM |
|---|---|---|---|---|
| Mar 2023 | ₹1,003 Cr | ₹99 Cr | ₹39.72 | 9.87% |
| Mar 2022 | ₹806 Cr | ₹62 Cr | ₹24.64 | 7.69% |
| Mar 2021 | ₹814 Cr | ₹93 Cr | ₹37.32 | 11.43% |
| Mar 2021 | ₹814 Cr | ₹93 Cr | ₹37.32 | 11.43% |
| Mar 2020 | ₹832 Cr | ₹72 Cr | ₹28.88 | 8.65% |
| Mar 2020 | ₹832 Cr | ₹72 Cr | ₹28.88 | 8.65% |
| Mar 2019 | ₹728 Cr | ₹54 Cr | ₹21.78 | 7.42% |
| Mar 2018 | ₹571 Cr | ₹26 Cr | ₹10.36 | 4.55% |
| Mar 2017 | ₹544 Cr | ₹20 Cr | ₹8.02 | 3.68% |
| Mar 2016 | ₹564 Cr | ₹5 Cr | ₹2.10 | 0.89% |
| Mar 2015 | ₹517 Cr | ₹-21.00 Cr | ₹-8.34 | -4.06% |
| Mar 2014 | ₹474 Cr | ₹-1.00 Cr | ₹-0.20 | -0.21% |
Peer comparison
Other companies in Pharmaceuticals
| Company | P/E | Book Value | Sales Growth |
|---|---|---|---|
| SUNPHARMA SUN PHARMACEUTICAL INDUSTRIES LTD. | 39.1 | ₹98.33 | 10.1% |
| MARKSANS MARKSANS PHARMA LTD. | 23.8 | ₹11.85 | 5.8% |
| MOREPENLAB MOREPEN LABORATORIES LTD. | 20.81 | ₹6.43 | 16.6% |
| NEULANDLAB NEULAND LABORATORIES LTD. | 23.48 | ₹542.16 | 9.35% |
| GUFICBIO Gufic BioSciences Ltd. | 24.16 | ₹10.85 | 20.41% |
| DIVISLAB DIVI'S LABORATORIES LTD. | 41.01 | ₹266.77 | 9.47% |
| DRREDDY DR.REDDY'S LABORATORIES LTD. | 19.73 | ₹852.69 | 1.07% |
| RPGLIFE RPG LIFE SCIENCES LTD. | 17.14 | ₹105.02 | 5.73% |
| GLAND Gland Pharma Ltd | 53.6 | ₹242.00 | — |
| ZYDUSLIFE Zydus Lifesciences Ltd | 8.23 | ₹166.00 | 5% |
| SMSPHARMA SMS PHARMACEUTICALS LTD. | 9.58 | ₹42.07 | -8.73% |
| CIPLA CIPLA LTD. | 15.36 | ₹209.71 | 0.7% |
Dividend history
Per share, by ex-date
Ex-Date: 07 Jul 2022₹8.00
Ex-Date: 18 Aug 2021₹2.00
Ex-Date: 20 Aug 2020₹2.00
Ex-Date: 20 Aug 2019₹1.00
Ex-Date: 09 Jul 2012₹3.50
Ex-Date: 07 Jul 2011₹10.00
Ex-Date: 06 May 2010₹10.00
Ex-Date: 29 Apr 2009₹15.00
Ex-Date: 11 Apr 2008₹15.00
Ex-Date: 18 Jun 2001₹4.00
Ex-Date: 11 Aug 2000₹0.50
Bulk & block deals
Recent large transactions
| Date | Client | Type | Qty | Price |
|---|---|---|---|---|
| 19 Sept 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | SALE | 74,097 | ₹3,152.55 |
| 19 Sept 2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | PURCHASE | 74,097 | ₹3,152.55 |
| 19 Sept 2022 | ISHARES INDIA SC MAURITIUS COMPANY | SALE | 6,542 | ₹3,152.55 |
| 19 Sept 2022 | ISHARES MSCI INDIA SMALL-CAP ETF | PURCHASE | 6,542 | ₹3,152.55 |
| 30 May 2013 | CROSSEAS CAPITAL SERVICES PRIVATE LIMITED | SALE | 1,26,180 | ₹845.63 |
Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.